L. Nandini Moorthy
YOU?
Author Swipe
View article: Evaluating Renal Disease in Pediatric‐Onset Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome
Evaluating Renal Disease in Pediatric‐Onset Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome Open
Objective We aimed to study the disease course, outcomes, and predictors of outcome in pediatric‐onset antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) affecting the kidneys. Methods Patients eligible for this study h…
View article: Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An <scp>ARChiVe</scp> Registry Cohort Study
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An <span>ARChiVe</span> Registry Cohort Study Open
Objective Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are chronic life‐threatening vasculitides requiring substantial immunotherapy. Adult trials identified rituximab (RTX) as an alternative to cyclophosphamid…
View article: Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework
Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework Open
View article: Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework
Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework Open
View article: Quality of life measures and physical activity in childhood systemic lupus erythematosus
Quality of life measures and physical activity in childhood systemic lupus erythematosus Open
Childhood systemic lupus erythematosus (cSLE) is a life-long disease with significant morbidity and mortality, and with associated significant impact on health-related quality of life (HRQOL). Previous literature supports that physical act…
View article: Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus
Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus Open
We report a case of COVID-19 in a pediatric patient with systemic lupus erythematosus (SLE), who presented with respiratory distress marked by increased work of breathing and low oxygen saturation. Lab tests confirmed COVID-19, and showed …
View article: Epidermal Neurite Density in Skin Biopsies From Patients With Juvenile Fibromyalgia
Epidermal Neurite Density in Skin Biopsies From Patients With Juvenile Fibromyalgia Open
Objective Fibromyalgia (FM) is defined by idiopathic, chronic, widespread musculoskeletal pain. In adults with FM, a metaanalysis of lower-leg skin biopsy demonstrated 45% pooled prevalence of abnormally low epidermal neurite density (END)…
View article: Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain
Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain Open
Introduction: Chronic musculoskeletal (MSK) pain has been associated with chronic illnesses and high rates of pain medication use, often in referral centers, European populations, or studies focused on single drug classes. We aimed to char…
View article: Making Decisions About Stopping Medicines for Well‐Controlled Juvenile Idiopathic Arthritis: A Mixed‐Methods Study of Patients and Caregivers
Making Decisions About Stopping Medicines for Well‐Controlled Juvenile Idiopathic Arthritis: A Mixed‐Methods Study of Patients and Caregivers Open
Objective Improved treatments for juvenile idiopathic arthritis (JIA) have increased remission rates. We conducted this study to investigate how patients and caregivers make decisions about stopping medications when JIA is inactive. Method…
View article: Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry
Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry Open
Objective The objective of this article is to describe and compare clinical features, treatment, and renal outcomes of children with membranous lupus nephritis (MLN), through analysis of a national multicenter registry. Methods Patients wi…
View article: Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting
Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting Open
View article: Simple screening tool for assessing attention deficit in pediatric lupus
Simple screening tool for assessing attention deficit in pediatric lupus Open
View article: Stratification of patients with autoinflammatory phenotypes by interferon (IFN) score suggests a new group of IFN mediated autoinflammatory diseases with overlapping clinical phenotypes
Stratification of patients with autoinflammatory phenotypes by interferon (IFN) score suggests a new group of IFN mediated autoinflammatory diseases with overlapping clinical phenotypes Open
View article: Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura
Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura Open
Thrombotic thrombocytopenic purpura (TTP) is a well-described complication of systemic lupus erythematosus (SLE).1 Historically, plasma exchange has been the mainstay of treatment for TTP as well as for other thrombotic microangiopathies.2…